DOI QR코드

DOI QR Code

Efficacy and safety of endoscopic ultrasound-guided hepaticogastrostomy for biliary drainage in hypervascular hepatocellular carcinoma: a retrospective study from Japan

  • Received : 2024.04.02
  • Accepted : 2024.07.29
  • Published : 2025.05.30

Abstract

Background/Aims: Biliary obstruction drainage in patients with hepatocellular carcinoma (HCC) is associated with symptom palliation, improved access to chemotherapy, and improved survival. Stent placement and exchange via endoscopic retrograde cholangiopancreatography biliary drainage risk traversing the HCC, a hypervascular tumor and causing bleeding. Endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) potentially prevents procedure-related bleeding. Therefore, we evaluated the efficacy and safety of EUS-HGS as an alternative treatment for biliary obstruction in patients with HCC. Methods: This was a retrospective study of all EUS-HGS procedures performed in patients with HCC at the Aichi Cancer Center Hospital, Japan, from February 2017 to August 2023. Results: A total of 14 EUS-HGS procedures (42.9% primary) were attempted in 10 HCC patients (mean age 71.5 years, 80.0% male). Clinical and technical success rates were 92.9% and 90.9%, respectively. The observed procedure details in the 13 successful procedures included B3 puncture (53.8%), 22-G needle (53.8%), fully covered self-expandable metal stent (100%), and mean procedure time (32.7 minutes). There was no bleeding. Mild complications occurred in 27.3%. All patients resumed oral intake within 24 hours. Conclusions: EUS-HGS is a technically feasible and clinically effective initial or salvage drainage option for the treatment of biliary obstruction in patients with HCC.

Keywords

References

  1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–249. https://doi.org/10.3322/caac.21660
  2. Qin LX, Tang ZY. Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis. World J Gastroenterol 2003;9:385–391. https://doi.org/10.3748/wjg.v9.i3.385
  3. Huang JF, Wang LY, Lin ZY, et al. Incidence and clinical outcome of icteric type hepatocellular carcinoma. J Gastroenterol Hepatol 2002;17:190–195. https://doi.org/10.1046/j.1440-1746.2002.02677.x
  4. Soyer P, Laissy JP, Bluemke DA, et al. Bile duct involvement in hepatocellular carcinoma: MR demonstration. Abdom Imaging 1995;20:118–121. https://doi.org/10.1007/BF00201517
  5. Woo HY, Han SY, Heo J, et al. Role of endoscopic biliary drainage in advanced hepatocellular carcinoma with jaundice. PLoS One 2017;12:e0187469. https://doi.org/10.1371/journal.pone.0187469
  6. Matsumi A, Kato H, Ueki T, et al. Effectiveness, safety, and factors associated with the clinical success of endoscopic biliary drainage for patients with hepatocellular carcinoma: a retrospective multicenter study. BMC Gastroenterol 2021;21:28. https://doi.org/10.1186/s12876-020-01594-4
  7. An J, Lee KS, Kim KM, et al. Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion. Clin Mol Hepatol 2017;23:160–169. https://doi.org/10.3350/cmh.2016.0088
  8. Minami Y, Kudo M. Hepatocellular carcinoma with obstructive jaundice: endoscopic and percutaneous biliary drainage. Dig Dis 2012;30:592–597. https://doi.org/10.1159/000343087
  9. Dumonceau JM, Tringali A, Papanikolaou IS, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline: updated October 2017. Endoscopy 2018;50:910–930. https://doi.org/10.1055/a-0659-9864
  10. Giovannini M, Moutardier V, Pesenti C, et al. Endoscopic ultrasound-guided bilioduodenal anastomosis: a new technique for biliary drainage. Endoscopy 2001;33:898–900. https://doi.org/10.1055/s-2001-17324
  11. Jagielski M, Zieliński M, Piątkowski J, et al. Outcomes and limitations of endoscopic ultrasound-guided hepaticogastrostomy in malignant biliary obstruction. BMC Gastroenterol 2021;21:202. https://doi.org/10.1186/s12876-021-01798-2
  12. Hara K, Yamao K, Hijioka S, et al. Prospective clinical study of endoscopic ultrasound-guided choledochoduodenostomy with direct metallic stent placement using a forward-viewing echoendoscope. Endoscopy 2013;45:392–396. https://doi.org/10.1055/s-0032-1326076
  13. Sportes A, Camus M, Greget M, et al. Endoscopic ultrasound-guided hepaticogastrostomy versus percutaneous transhepatic drainage for malignant biliary obstruction after failed endoscopic retrograde cholangiopancreatography: a retrospective expertise-based study from two centers. Therap Adv Gastroenterol 2017;10:483–493. https://doi.org/10.1177/1756283X17702096
  14. Isayama H, Nakai Y, Itoi T, et al. Clinical practice guidelines for safe performance of endoscopic ultrasound/ultrasonography-guided biliary drainage: 2018. J Hepatobiliary Pancreat Sci 2019;26:249–269. https://doi.org/10.1002/jhbp.631
  15. Aithal GP, Palaniyappan N, China L, et al. Guidelines on the management of ascites in cirrhosis. Gut 2021;70:9–29. https://doi.org/10.1136/gutjnl-2020-321790
  16. Nass KJ, Zwager LW, van der Vlugt M, et al. Novel classification for adverse events in GI endoscopy: the AGREE classification. Gastrointest Endosc 2022;95:1078–1085. https://doi.org/10.1016/j.gie.2021.11.038
  17. Li J, Tang J, Liu F, et al. Comparison of choledochoduodenostomy and hepaticogastrostomy for EUS-guided biliary drainage: a meta-analysis. Front Surg 2022;9:811005. https://doi.org/10.3389/fsurg.2022.811005
  18. Uemura RS, Khan MA, Otoch JP, et al. EUS-guided choledochoduodenostomy versus hepaticogastrostomy: a systematic review and meta-analysis. J Clin Gastroenterol 2018;52:123-130. https://doi.org/10.1097/MCG.0000000000000948
  19. Yasuda T, Hara K, Mizuno N, et al. Safety of endoscopic ultrasound-guided hepaticogastrostomy in patients with malignant biliary obstruction and ascites. Clin Endosc 2024;57:246-252. https://doi.org/10.5946/ce.2023.075
  20. Yamada M, Hara K, Haba S, et al. Endoscopic ultrasound-guided hepaticogastrostomy using a novel drill dilator. Endoscopy 2022;54(S 02):B856-E857. https://doi.org/10.1055/a-1838-3682
  21. Hara K, Okuno N, Haba S, et al. How to perform EUS-guided hepaticogastrostomy easier and safer. J Hepatobiliary Pancreat Sci 2020;27:563-564. https://doi.org/10.1002/jhbp.774
  22. Iwashita T, Ogura T, Ishiwatari H, et al. Utility of dedicated bougie dilator for a 0.018-inch guidewire during EUS-guided biliary drainage: a multi-center retrospective cohort study. J Hepatobiliary Pancreat Sci 2022;29:810-816. https://doi.org/10.1002/jhbp.1021
  23. Ogura T, Ueno S, Okuda A, et al. Expanding indications for endoscopic ultrasound-guided hepaticogastrostomy for patients with insufficient dilatation of the intrahepatic bile duct using a 22G needle combined with a novel 0.018-inch guide wire (with video). Dig Endosc 2022;34:222-227. https://doi.org/10.1111/den.14101
  24. Sugiyama G, Okabe Y, Ishida Y, et al. Evaluation of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma. World J Gastroenterol 2014;20:6968-6973. https://doi.org/10.3748/wjg.v20.i22.6968
  25. Okuno N, Hara K, Mizuno N, et al. Efficacy of the 6-mm fully covered self-expandable metal stent during endoscopic ultrasound-guided hepaticogastrostomy as a primary biliary drainage for the cases estimated difficult endoscopic retrograde cholangiopancreatography: a prospective clinical study. J Gastroenterol Hepatol 2018;33:1413-1421. https://doi.org/10.1111/jgh.14112
  26. Winkler J, Caillol F, Ratone JP, et al. Feasibility of EUS-guided hepaticogastrostomy for inoperable malignant hilar biliary strictures. Endosc Ultrasound 2021;10:51-56. https://doi.org/10.4103/eus.eus_68_20
  27. Paik WH, Park DH. Outcomes and limitations: EUS-guided hepaticogastrostomy. Endosc Ultrasound 2019;8(Suppl 1):S44-S49. https://doi.org/10.4103/eus.eus_51_19
  28. Nakai Y, Kogure H, Isayama H, et al. Endoscopic ultrasound-guided biliary drainage for unresectable hilar malignant biliary obstruction. Clin Endosc 2019;52:220-225. https://doi.org/10.5946/ce.2018.094
  29. Kiyosawa K, Umemura T, Ichijo T, et al. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 2004;127(5 Suppl 1):S17-S26. https://doi.org/10.1053/j.gastro.2004.09.012